Hydrochlorothiazide is the most commonly prescribed thiazide diuretic. It is indicated to treat edema and hypertension. Hydrochlorothiazide use is common but declining in favour of angiotensin converting enzyme inhibitors. Many combination products are available containing hydrochlorothiazide and angiotensin converting enzyme inhibitors or angiotensin II rec...
Hydrochlorothiazide is indicated alone or in combination for the management of edema associated with congestive heart failure, hepatic cirrhosis, nephrotic syndrome, acute glomerulonephritis, chronic renal failure, and corticosteroid and estrogen therapy. Hydrochlorothiazide is also indicated alone or in combination for the management of hypertension.
UBC Hospital, Vancouver, British Columbia, Canada
Mayo Clinic, Rochester, Minnesota, United States
University of Florida Department of Community Health and Family Medicine, Gainesville, Florida, United States
Emory University, Atlanta, Georgia, United States
Vanderbilt University, Nashville, Tennessee, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Novartis Pharmaceuticals, Basel, Switzerland
Novartis Pharmaceuticals, Basel, Switzerland
Boehringer Ingelheim Investigational Site, Taya-gun, Gunma, Japan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.